Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog

Category: biotech/medical – Page 320

Parkinson’s Discovery Suggests We May Have an FDA-Approved Treatment Already

Researchers have discovered how a surface protein on brain cells, called Aplp1, can play a role in spreading material responsible for Parkinson’s disease from cell to cell in the brain.

Promisingly, an FDA-approved cancer drug that targets another protein – Lag3 – which interacts with Aplp1 – was found to block this process in mice. This suggests a potential treatment for Parkinson’s may already exist.

In a paper published last year, an international team of scientists detailed how the two proteins work together to help toxic clumps of alpha-synuclein protein get into brain cells.

Microscopic DNA ‘Flowers’ Could Transform Targeted Drug Delivery

Researchers at the University of North Carolina (UNC) have developed microscopic flower-shaped soft robots made from DNA and inorganic materials that can fold, bend, and react to their environment. Detailed in a paper published in Nature Nanotechnology, these microscopic DNA “flowers” are a potential new method for targeted drug delivery and other biomedical applications.

“People would love to have smart capsules that would automatically activate medication when it detects disease and stops when it is healed. In principle, this could be possible with our shapeshifting materials,” said senior author Ronit Freeman, PhD, and associate professor at USC and leader of a research group that is seeking to develop novel designer materials using self-assembling biological components.

The DNA flowers are assembled from hybrid DNA, inorganic crystals that respond to environmental stimuli such as changes in acidity (pH), enabling reversible changes in shape—shrinking, bending, and folding—within seconds. The petals can open or close in response to local environmental conditions, motion that can be used to trigger a chemical reaction, release molecules, or interact with tissues.

MIT’s “stealth” immune cells could change cancer treatment forever

Engineered “stealth” immune cells from MIT and Harvard show promise for fast, safe, and powerful cancer treatment. Scientists have created a new and more advanced form of immune-based cancer therapy using engineered cells known as CAR-NK (natural killer) cells. Like CAR-T cells, these modified immune cells can be programmed to recognize and attack cancer, but they rely on a different type of immune cell that naturally targets abnormal or infected cells.

A team from MIT and Harvard Medical School has now developed a more effective way to engineer CAR-NK cells that dramatically reduces the chance of the body’s immune system rejecting them. Immune rejection has been one of the biggest limitations of cell-based therapies, often weakening their effectiveness.

This innovation could also make it possible to produce “off-the-shelf” CAR-NK treatments that are available immediately after diagnosis, rather than waiting weeks for custom-engineered cells. Traditional CAR-NK and CAR-T manufacturing methods typically require several weeks to complete before patients can begin treatment.

Strong evidence supports skin-to-skin contact after birth as standard care

Immediate skin-to-skin contact between newborns and their mothers offers a better start in life, improving a number of key health metrics, according to a newly-updated Cochrane review.

The , published in the Cochrane Database of Systematic Reviews, found that babies who have skin-to-skin contact with their mother within the first hour of birth are more likely to see a variety of benefits, including exclusive breastfeeding, optimal body temperatures and blood sugar levels.

While possible benefits for the mother were also studied, such as effects on and timing of placental delivery, the evidence was less certain.

Examining Chronic Inflammation, Immune Metabolism, and T Cell Dysfunction in HIV Infection

Chronic Human Immunodeficiency Virus (HIV) infection remains a significant challenge to global public health. Despite advances in antiretroviral therapy (ART), which has transformed HIV infection from a fatal disease into a manageable chronic condition, a definitive cure remains elusive. One of the key features of HIV infection is chronic immune activation and inflammation, which are strongly associated with, and predictive of, HIV disease progression, even in patients successfully treated with suppressive ART. Chronic inflammation is characterized by persistent inflammation, immune cell metabolic dysregulation, and cellular exhaustion and dysfunction.

Women better protected against early neurodegeneration in Parkinson’s disease, study reveals

A large international study involving nearly 700 participants reveals that women with a precursor condition to Parkinson’s disease show significantly less brain atrophy—decreased cortical thickness in the brain—than men, despite similar clinical severity. This discovery, published in the journal Nature Communications, could lead scientists to explore the role that hormones might play in treating the disease.

Isolated REM sleep behavior disorder is characterized by violent movements during sleep, where people literally “act out” their dreams. Far from being harmless, this disorder is the most reliable early warning sign of neurodegenerative diseases caused by the accumulation of a toxic protein in the brain: more than 70% of affected individuals will eventually develop Parkinson’s disease, Lewy body dementia, or, more rarely, multiple system atrophy (a disease affecting multiple body systems).

“This sleep disorder offers a unique window of opportunity to study the mechanisms of neurodegeneration before major motor or cognitive symptoms appear,” explains Shady Rahayel, professor at UdeM’s Faculty of Medicine and leader of this study.

Shanghai Tower serves as inspiration for first synthetic dynamic helical polymer

Researchers at the University of Groningen in the Netherlands have developed a polymer that adopts a coiled spring configuration at low temperatures and unfolds again upon heating. Furthermore, the molecule can break down into smaller molecules under certain conditions. The Shanghai Tower, with its spiral shape, served as the inspiration for the project following a visit five years ago. A description of the resulting helical polymer was recently published in Nature Chemistry.

Spiraling structures are common in . A well-known example is the double helix of DNA; another is the alpha-helix domains in proteins. Various artificial helices have been created, some of which can change their shape. Other can be recycled into their monomers, but so far, no polymers have been developed that can both change shape and be recycled into their .

Study unveils mechanisms driving axonal accumulation of TDP-43 and associated nerve damage in ALS

Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterized by progressive muscle wasting and limb paralysis. This neurodegenerative condition results from the gradual destruction of motor neurons, the nerve cells that control muscles.

Past neuroscience studies have identified a TAR DNA-binding protein that plays a key role in ALS, known as TDP-43. This protein, which generally regulates RNA processing (i.e., how genetic information is managed inside cells), was found to abnormally accumulate in the axons (i.e., nerve fibers) of patients diagnosed with ALS.

Researchers at Tel Aviv University, Sheba Medical Center and other institutes carried out a study aimed at further exploring the mechanisms that underpin this local aggregation of TDP-43 in axons.

Study reveals Parkinson’s protein clumps rob brain cells of vital energy

A new study led by Rice University’s Pernilla Wittung-Stafshede has revealed that protein clumps, or plaques that clog the brain, associated with Parkinson’s disease are not merely waste; they can actively drain energy from brain cells. These clumps, composed of a protein called alpha-synuclein, were found to break down adenosine triphosphate (ATP), the molecule responsible for powering nearly all cellular activities.

Published in Advanced Science, the research demonstrates that when ATP binds to these , the reshapes itself to trap the molecule in a small pocket. This process causes ATP to break apart and release energy, functioning similarly to an enzyme.

This unexpected finding could change scientists’ understanding of the damage caused by these clumps, which are hallmarks of diseases such as Parkinson’s and Alzheimer’s.

New brain imaging technique can detect early frontotemporal dementia

A new international study led by researchers at Karolinska Institutet demonstrates that it is possible to detect subtle changes in the brain and identify early signs of hereditary frontotemporal dementia using advanced brain imaging techniques. The study is published in Molecular Psychiatry.

Frontotemporal dementia, or FTD, is a neurodegenerative disease that often affects people in middle age and is a common cause of dementia before the age of 65. The disease is particularly difficult to diagnose in its early stages, as the earliest symptoms are behavioral changes and may resemble primary psychiatric disease and symptoms later on can resemble conditions such as Alzheimer’s disease and Parkinson’s disease. In about a third of cases, is hereditary, making families with known mutations an important resource for research.

/* */